Ulvera AI

AI-based Ultrasound Device for Skin Tightening and Fat Reduction

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in March 2020 by Dom Serafino, Yoram Eshel, and Ines Verner, Ulvera AI operates with 1–10 employees. The company is currently in the Pre-Funding stage and is developing an AI-based ultrasound device for non-invasive body contouring. A key development for the company was the appointment of Domenic Serafino as CEO and Co-founder in January 2025.

Business overview

Ulvera AI is developing an AI-based, non-invasive, hands-free ultrasound device for skin tightening and fat reduction. The company's proprietary, patent-pending technology utilizes Quasi Focused Ultrasound to precisely heat and stimulate the dermis, subcutaneous fat, superficial fascia, and muscle. This system dynamically adjusts ultrasonic beam parameters and energy deposition depth to cater to individual patient needs, serving the health tech, life sciences, and aesthetics markets.

Strategic signal

Ulvera AI is strategically strengthening its leadership team, signaling a focus on market penetration and operational scaling. The appointment of Domenic Serafino as CEO and Co-founder in January 2025, followed by Grant Stevens, MD, as Executive Chairman in February 2025, indicates a concerted effort to bring experienced leadership to guide the company through its product development and commercialization phases. This move suggests a push towards solidifying its position in the non-invasive body contouring market.

Company Intelligence Q&A

What is Ulvera AI's core product?
Ulvera AI is developing an AI-based, non-invasive, hands-free ultrasound device designed for skin tightening and fat reduction, utilizing proprietary Quasi Focused Ultrasound technology.
When was Ulvera AI founded and by whom?
Ulvera AI was founded in March 2020 by Dom Serafino, Yoram Eshel, and Ines Verner.
Who was appointed as CEO and Co-founder of Ulvera AI?
In January 2025, Ulvera AI appointed Domenic Serafino as its CEO and Co-founder.
Who joined Ulvera AI as Executive Chairman?
In February 2025, Ulvera AI announced the appointment of Grant Stevens, MD, as Executive Chairman.
What is the current product development stage of Ulvera AI?
Ulvera AI's product is currently in the Clinical Trial stage, indicating it is undergoing testing to evaluate its safety and efficacy before potential market release.

External links